Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. In a recent update, Eli Lilly and Company announced the ...

Colorectal cancer (CRC) is a significant global health concern, originating from precancerous polyps in the colon or rectum and progressing through ...

Immuneering (NASDAQ:IMRX) said it has entered into a clinical supply agreement with Eli Lilly (NYSE:LLY) for its cancer drug ...

Immuneering to evaluate atebimetinib in combination with olomorasib in planned Phase 2 trial in patients with advanced non-small cell lung cancer – CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- ...

© 2001-2025 Plasteurope.com | Imprint | Privacy | Cookie settings ...